Opendata, web and dolomites

Fingers4Cure

Zinc finger gene therapy in the brain for treating Huntington's disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Fingers4Cure project word cloud

Explore the words cloud of the Fingers4Cure project. It provides you a very rough idea of what is the project "Fingers4Cure" about.

diagnosis    suffering    finger    zfps    garriga    national    et    artificially    critical    109    neurodegenerative    brain    devastating    start    intellectual    2012    therapy    huntington    repressors    improvements    curative    proteins    proprietary    intervention    e3145    accomplished    proc    toxic    mice    licenses    inherited    35    htt    dna    proof    industry    engaging    protein    humans    regional    ipr    single    disorder    carers    sci    viral    carry    phases    unrelated    occurring    data    e3136    expanded    expression    coding    earlier    45    lethal    gene    huntingtin    isalan    parallel    clinic    usa    reducing    function    levels    disease    synthetic    r6    zinc    vectors    patients    published    maintaining    hd    represses    grant    repression    mutant    canut    defective    symptoms    acad    engineered    muscle    moves    binding    reduce    generally    basis    synthesis    bind    efficient    arise    mouse    death    property    patent    demonstrating    cure    al    market    natl    15    protect    age    sequences    normal   

Project "Fingers4Cure" data sheet

The following table provides information about the project.

Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE 

Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ
website: http://www.imperial.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 149˙995 €
 EC max contribution 149˙995 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-PoC
 Funding Scheme ERC-POC
 Starting year 2015
 Duration (year-month-day) from 2015-02-01   to  2016-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) coordinator 149˙995.00

Map

 Project objective

Huntington’s disease (HD) is a lethal inherited neurodegenerative disorder which currently has no cure. Patients develop a devastating loss of muscle control and brain function, with symptoms typically developing at 35 - 45 years of age, although they can start much earlier. Suffering is high for both patients and carers, with death generally occurring within 10 - 15 years of diagnosis. We are working on a novel, curative gene therapy approach based on reducing the levels of the HTT disease gene products, while maintaining the levels of the normal protein. It is based on the delivery of proprietary zinc finger proteins (ZFPs) to the brain. Efficient delivery is accomplished through the use of viral vectors that carry the sequences coding for our ZFPs. Such ZFPs are artificially engineered proteins that specifically bind the defective expanded HTT DNA sequences (but not the normal HTT sequences or other, unrelated sequences). Binding represses the synthesis of the toxic gene products. We have published data demonstrating efficient mutant HTT repression in mouse (Garriga-Canut, M., et al. & Isalan M. Synthetic zinc finger repressors reduce mutant Huntingtin expression in the brain of R6/2 mice. Proc Natl Acad Sci USA 109: E3136-E3145, 2012). We now need to improve the viral vectors for the long term expression of our ZFPs in the mouse brain, as the basis for a single-intervention, long-term therapy in humans (technical improvements). In parallel, we need to maintain the patent applications that protect the technology through various national and regional phases, and protect new developments that may arise (intellectual property), while engaging the necessary IPR and market studies/activities that help us find an industry partner that licenses our technology and moves it forward into the clinic (exploitation). This proof of concept grant is critical in all three aspects.

 Publications

year authors and title journal last update
List of publications.
2015 Michal Mielcarek, Mark Isalan
A shared mechanism of muscle wasting in cancer and Huntington’s disease
published pages: , ISSN: 2001-1326, DOI: 10.1186/s40169-015-0076-z
Clinical and Translational Medicine 4/1 2019-07-23
2016 Carmen Agustín-Pavón, Michal Mielcarek, Mireia Garriga-Canut, Mark Isalan
Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice
published pages: , ISSN: 1750-1326, DOI: 10.1186/s13024-016-0128-x
Molecular Neurodegeneration 11/1 2019-07-23
2015 Michal Mielcarek
Huntington\'s disease is a multi-system disorder
published pages: e1058464, ISSN: 2167-5511, DOI: 10.1080/21675511.2015.1058464
Rare Diseases 3/1 2019-07-23

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FINGERS4CURE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FINGERS4CURE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

evolSingleCellGRN (2019)

Constraint, Adaptation, and Heterogeneity: Genomic and single-cell approaches to understanding the evolution of developmental gene regulatory networks

Read More  

HEIST (2020)

High-temperature Electrochemical Impedance Spectroscopy Transmission electron microscopy on energy materials

Read More  

IMMUNOTHROMBOSIS (2019)

Cross-talk between platelets and immunity - implications for host homeostasis and defense

Read More